Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000600025 | SCV000711056 | uncertain significance | not specified | 2020-06-08 | criteria provided, single submitter | clinical testing | The p.Val4907Phe variant in ADGRV1 has not been previously reported in individuals with hearing loss or Usher syndrome, but it has been identified in 0.007% (8/112882) European chromosomes by gnomAD (http://gnomad.broadinstitute.org). It has been reported in ClinVar (Variation ID 504584). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational prediction tools and conservation analyses suggest that this variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Val4907Phe variant is uncertain. ACMG/AMP Criteria applied: PM2, BP4. |
Fulgent Genetics, |
RCV000765857 | SCV000897253 | uncertain significance | Usher syndrome type 2C; Febrile seizures, familial, 4 | 2018-10-31 | criteria provided, single submitter | clinical testing |